Organization | Moscow State University

Moscow State University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Moscow Russian Federation (1755)

Organization Overview

First Clinical Trial

2007

NCT01709682

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Central Clinical Hospital with Polyclinic | Federal State Budgetary Educational Institution of Higher Education "Bashkir State Medical University" of the Ministry of Healthcare of the Russian Federation | First Moscow State Medical University named after IM Sechenov, Health Ministry of the Russian Federation, Outpatient Department | Head of the Department Diseases of the ear, nose and throat ,Moscow State Medical Dental University of the Ministry of Health of Russia, Otorhinolaryngology Department of Postgraduate Studies Faculty | Lomonosov Moscow State University Medical Research and Educational Center | Meshalkin Research Institute of Pathology of Circulation | Moscow State University | Moscow State University n.a. M.V. Lomonosov | Moscow State University of Medicine and Dentistry | Moscow state university of medicine and dentistry named after A.I. Evdokimov | O.M. Filatov Municipal Clinical Hospital N 15 | State Budgetary Higher Vocational Education Institution A.I. Evdokimov Moscow State University of Medicine and Dentistry | State Budgetary Higher Vocational Education Institution I.M. Sechenov First Moscow State Medical University | State Budgetary Higher Vocational Education Institution Pacific State Medical University, Ministry of Health of the Russian Federation | State Budgetary Higher Vocational Education Institution V.I. Razumovsky Saratov State University of medicine | State Budgetary Institution of Higher Professional Education A.I. Evdokimov Moscow State Medical Dental University of the Ministry of Health of Russia | State Educational Establishment of Higher Professional Education Russian State Medical University of Federal Service on Surveillance in Healthcare and Social Development of Russian Federation | The First Moscow State Sechenov Medical University

Active Ingredients

Drugs in Phase 4 Trials (9)

calcium chloride (1 trial)

dabigatran (pradaxa) (1 trial)

esmolol (brevibloc) (1 trial)

nimesulide (1 trial)

propofol (diprivan) (2 trials)

sevoflurane (ultane) (1 trial)

sodium chloride (6 trials)

thiamine (1 trial)

warfarin (coumadin) (4 trials)

Drugs in Phase 3 Trials (18)

acetylsalicylic acid (aspirin) (2 trials)

bromhexine (1 trial)

favipiravir (1 trial)

glucose (1 trial)

icosapent ethyl (vascepa) (1 trial)

interferon alpha-2b (Intron-A) (3 trials)

lactulose (cephulac) (1 trial)

metoprolol (lopressor) (2 trials)

molixan (1 trial)

n(2)-l-alanine l-glutamine dipeptide (1 trial)

phosphocreatine (1 trial)

ribavirin (virazole) (1 trial)

rimabotulinumtoxinB (Myobloc) (9 trials)

soybean oil (Intralipid) (1 trial)

spironolactone (aldactone) (1 trial)

tafluprost (zioptan) (1 trial)

verapamil (calan) (1 trial)

Drugs in Phase 2 Trials (14)

amiodarone (cordarone) (1 trial)

bcd-085 (1 trial)

colchicine (colbenemid) (1 trial)

flecainide (tambocor) (1 trial)

hydroxyethyl starch (voluven) (1 trial)

iloprost (ventavis) (1 trial)

lisinopril (zestril) (1 trial)

melphalan (alkeran) (2 trials)

propafenone (rythmol) (1 trial)

ruxolitinib (jakafi) (1 trial)

secukinumab (cosentyx) (1 trial)

sodium succinate (1 trial)

sotalol (betapace) (1 trial)

vitamin c (1 trial)

Drugs in Phase 1 Trials (5)

apixaban (eliquis) (1 trial)

clopidogrel (plavix) (1 trial)

follitropin alfa (Gonal-F) (1 trial)

indomethacin (indocin) (1 trial)

sildenafil (viagra) (1 trial)

Drugs in Other Trials (2)

formoterol (foradil) (1 trial)

tiotropium (spiriva) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acquired Immunodeficiency Syndrome (Phase 3)

Acute Coronary Syndrome (Phase 2)

Atrial Fibrillation (Phase 3)

Atrial Flutter (Phase 2)

Bronchiectasis (Phase 2)

Carcinoma, Renal Cell (Phase 4)

Cholangitis (Phase 2)

Coinfection (Phase 3)

Coronary Artery Disease (Phase 3)

Coronary Disease (Phase 3)

Coronavirus Infections (Phase 3)

Delirium (Phase 4)

Dermatitis (Phase 3)

Dermatitis, Atopic (Phase 3)

Eczema (Phase 3)

Embolism (Phase 4)

Fatty Liver (Phase 2)

Fibrosis (Phase 2)

Glaucoma (Phase 3)

Glaucoma, Open-Angle (Phase 3)

Heart Arrest (Phase 1)

Heart Defects, Congenital (Phase 3)

Heart Diseases (Phase 3)

Hepatitis (Phase 3)

Hepatitis A (Phase 3)

Hepatitis C (Phase 3)

Hepatitis C, Chronic (Phase 3)

HIV Infections (Phase 3)

Hypertension (Phase 3)

Hypertension, Pulmonary (Phase 2)

Immunologic Deficiency Syndromes (Phase 3)

Infarction (Phase 2)

Kidney Neoplasms (Phase 4)

Liver Cirrhosis (Phase 2)

Liver Cirrhosis, Biliary (Phase 2)

Liver Diseases (Phase 2)

Myocardial Infarction (Phase 2)

Myocardial Ischemia (Phase 3)

Non-alcoholic Fatty Liver Disease (Phase 2)

Ocular Hypertension (Phase 3)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Pneumonia (Phase 2)

Pneumonia, Viral (Phase 2)

Prostatic Neoplasms (Phase 1)

Pulmonary Embolism (Phase 4)

Respiratory Aspiration (Phase 2)

Severe Acute Respiratory Syndrome (Phase 3)

Signs and Symptoms (Phase 3)

Syndrome (Phase 2)

Tachycardia (Phase 2)

Tachycardia, Ventricular (Phase 2)

Ventricular Premature Complexes (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 47
# of Trial APIs: 48